Coronary Flow Reserve Calculated From Pressure Measurements In Humans

Estimate coronary flow reserve (CFR) in humans using invasive pressure-wire thermodilution inputs. Primary formula: CFR = Resting Mean Transit Time / Hyperemic Mean Transit Time.

Expert Guide: Coronary Flow Reserve Calculated From Pressure Measurements in Humans

Coronary flow reserve (CFR) is one of the most informative physiologic metrics in invasive and noninvasive cardiology because it captures the ability of the coronary circulation to increase blood flow above resting demand. In practical terms, CFR answers a high-value clinical question: when the myocardium needs more oxygen, can the coronary system deliver it? If the answer is no, ischemia can occur even when anatomy looks only mildly abnormal, and this is especially important in diffuse atherosclerosis and coronary microvascular dysfunction.

In the catheterization laboratory, CFR can be estimated with pressure-wire technology using thermodilution. In this method, saline injections and transit-time analysis are performed at rest and at maximal hyperemia. Because flow is inversely related to mean transit time, the CFR equation becomes straightforward:

CFR = Resting mean transit time (Tmn) / Hyperemic mean transit time (Tmn)

The practical value is significant: the same pressure-temperature wire can provide multiple physiological signals in one procedure, including FFR (fractional flow reserve), pressure ratios, and thermodilution-based CFR. This offers a more complete hemodynamic profile than angiography alone. In humans, this integrated approach is frequently used to distinguish epicardial stenosis from microvascular disease and to explain symptoms when angiography is nondiagnostic.

Why CFR matters clinically

• It measures vasodilator capacity: CFR quantifies the ratio of hyperemic to resting flow.
• It reflects both epicardial and microvascular compartments: this makes it broader than lesion-specific pressure-only indices.
• It improves risk stratification: reduced CFR has repeatedly been associated with increased adverse cardiovascular outcomes in multiple human cohorts.
• It supports mechanism-based therapy: low CFR can guide lipid therapy intensity, anti-anginal strategy, and further microvascular-focused evaluation.

Burden of ischemic and coronary disease: why physiology is needed

Coronary physiology should be interpreted in the context of population burden. U.S. cardiovascular disease remains highly prevalent, and this makes precise hemodynamic phenotyping clinically relevant at scale. The statistics below illustrate why functional testing and invasive physiologic assessment remain central in modern practice.

Population metric (U.S.)	Reported value	Clinical implication for CFR use
Deaths from heart disease (2022)	702,880 deaths	Large outcome burden supports stronger physiologic risk detection and earlier preventive escalation.
Share of all U.S. deaths due to heart disease	About 1 in 5 deaths	Even modest improvements in ischemia diagnosis can have major public health impact.
Coronary heart disease deaths (2022)	371,506 deaths	Coronary-focused tools like CFR remain highly relevant in both obstructive and nonobstructive presentations.
Annual heart attacks in the U.S.	About 805,000 events/year	Recurrent risk identification after index events can be improved by physiologic profiling.

Data summarized from U.S. public health reporting by CDC/NHLBI.

How pressure-wire thermodilution CFR is measured in humans

1. Advance a pressure-temperature guidewire distal to the target lesion or vessel segment.
2. Equalize pressure signals at the guide catheter and verify waveform quality.
3. Record resting pressure data and perform repeated saline injections to determine resting Tmn.
4. Induce maximal hyperemia (commonly adenosine protocol).
5. Repeat saline injections to obtain hyperemic Tmn.
6. Compute CFR as resting Tmn divided by hyperemic Tmn.
7. Interpret alongside FFR, resting Pd/Pa, symptoms, ECG, and imaging context.

Because transit-time methods depend on signal quality and physiologic steadiness, repeatability is essential. Most labs perform multiple injections and use averaged values. Any significant drift, arrhythmia, damping, or catheter instability can bias results. Therefore, an expert reading of CFR always includes procedural quality control, not just the final numeric output.

Typical physiologic interpretation framework

Thresholds vary slightly by lab and population, but these ranges are commonly used in human invasive physiology. They should always be interpreted with clinical context and not as isolated binary rules.

Index	Typical threshold	Common interpretation
CFR (thermodilution)	≥2.5 often considered preserved	Adequate hyperemic augmentation in many settings.
CFR (borderline)	2.0 to 2.49	Intermediate vasodilator capacity; interpret with symptoms and pressure data.
CFR (impaired)	<2.0	Reduced reserve; may reflect epicardial disease, microvascular dysfunction, or both.
FFR	≤0.80 (hyperemic Pd/Pa)	Hemodynamically significant epicardial stenosis is likely.

Combining CFR with pressure indices improves diagnostic precision

A frequent clinical scenario is discordance between CFR and FFR. This is not an error; it is often the key to diagnosis. For example, low CFR with preserved FFR can suggest microvascular dysfunction, diffuse disease, or elevated resting flow. Conversely, low FFR with relatively preserved CFR may appear in focal epicardial disease with less global microvascular impairment. For this reason, integrated coronary physiology is usually more informative than single-index interpretation.

• Low CFR + low FFR: mixed epicardial and flow limitation, often higher ischemic burden.
• Low CFR + normal FFR: consider microvascular dysfunction, diffuse atherosclerosis, anemia, tachycardia, or high resting flow states.
• Normal CFR + low FFR: can occur in focal stenosis with maintained global reserve, depending on territory and hemodynamics.
• Normal CFR + normal FFR: physiologically reassuring in many stable settings.

Outcome relevance in human studies

Across invasive and noninvasive cohorts, impaired CFR has been associated with increased major adverse cardiovascular events. While exact hazard ratios differ by population, imaging modality, follow-up duration, and whether obstructive disease is present, many studies report materially higher risk in reduced-CFR groups, often in the approximate twofold range or greater compared with preserved CFR groups. This supports CFR as both a diagnostic and prognostic biomarker, especially when interpreted with comprehensive clinical data.

Common pitfalls when calculating CFR from pressure-wire data

• Inadequate hyperemia: insufficient vasodilation can falsely lower measured reserve.
• Pressure drift: uncorrected drift alters related pressure indices and can confuse combined interpretation.
• Irregular rhythm: beat-to-beat variability may distort transit-time averaging.
• Poor injection consistency: thermodilution requires reproducible bolus technique.
• Ignoring hemodynamic context: blood pressure, heart rate, LV filling pressures, and systemic illness can affect resting flow and CFR.

How to use the calculator on this page

1. Enter resting and hyperemic mean transit times in seconds.
2. Enter Pa and Pd values for rest and hyperemia.
3. Click Calculate CFR.
4. Review CFR, FFR, resting Pd/Pa, and interpretation category.
5. Use the chart to visually compare resting versus hyperemic conditions.

This calculator is educational and should not replace formal cath-lab software, institutional protocols, or specialist judgment. In clinical practice, final interpretation should integrate angiography, symptom burden, ECG/imaging ischemia evidence, hemodynamics, and patient-level comorbidity.

Authoritative public references

• CDC: Heart Disease Facts
• NHLBI (NIH): Coronary Heart Disease
• NCBI Bookshelf: Coronary Flow Reserve overview

Bottom line

Coronary flow reserve calculated from pressure-wire thermodilution in humans is a practical, clinically meaningful way to quantify coronary vasodilator function. The equation itself is simple, but interpretation is sophisticated and most powerful when combined with pressure-derived lesion assessment. In modern coronary care, CFR helps uncover hidden ischemic mechanisms, refine risk, and support more individualized treatment decisions.